New Launch5 Feb 2026, 02:19 am
Vineet Laboratories Ltd. Receives Trading Approvals for Rights Issue Equity Shares
AI Summary
Vineet Laboratories Ltd. has announced the receipt of trading approvals from BSE and NSE for the equity shares allotted under the Rights Issue of the company. A total of 99,87,258 equity shares have been allotted, which will be listed and admitted to dealings on both exchanges from February 5, 2026. This development is in accordance with the SEBI (LODR), 2015 regulations.
Key Highlights
- Vineet Laboratories Ltd. receives trading approvals from BSE and NSE for Rights Issue Equity Shares.
- 99,87,258 equity shares allotted under the Rights Issue.
- Equity shares to be listed and admitted to dealings on both exchanges from February 5, 2026.
- Development in accordance with SEBI (LODR), 2015 regulations.
Price Impact
More from VINEETLAB